A detailed history of Pinnacle Private Wealth, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pinnacle Private Wealth, LLC holds 30,445 shares of BCRX stock, worth $233,513. This represents 0.13% of its overall portfolio holdings.

Number of Shares
30,445
Previous 30,045 1.33%
Holding current value
$233,513
Previous $489,000 34.15%
% of portfolio
0.13%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

BUY
$7.89 - $17.88 $3,156 - $7,152
400 Added 1.33%
30,445 $322,000
Q4 2021

Feb 07, 2022

BUY
$11.18 - $15.46 $335,903 - $464,495
30,045 New
30,045 $416,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.43B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Pinnacle Private Wealth, LLC Portfolio

Follow Pinnacle Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Private Wealth, LLC with notifications on news.